These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12511921)

  • 21. The human use of humanoid beings: chimeras and patent law.
    Rabin S
    Nat Biotechnol; 2006 May; 24(5):517-9. PubMed ID: 16680130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The morality of biotech patents: differing legal obligations in Europe?
    Ford R
    Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
    [No Abstract]   [Full Text] [Related]  

  • 23. Recommended response for human cloning patent applications.
    Nash D
    IDEA J Law Technol; 2002; 42(2):279-312. PubMed ID: 15732181
    [No Abstract]   [Full Text] [Related]  

  • 24. Shortened life spans of biotech pioneer patents in Japan: a lesson from the DNA chip.
    Aida T; Konishi A; Hagiwara M; Hashimoto K
    Nat Biotechnol; 2007 May; 25(5):533-5. PubMed ID: 17483834
    [No Abstract]   [Full Text] [Related]  

  • 25. Companies balk at California's patent rules for stem cell research.
    Keim B
    Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
    [No Abstract]   [Full Text] [Related]  

  • 26. To patent or not to patent: the European Union's new biotech directive.
    Nenow L
    Houst J Int Law; 2001; 23(3):569-607. PubMed ID: 12769115
    [No Abstract]   [Full Text] [Related]  

  • 27. French refuse to implement biotech patent directive.
    Louët S
    Nat Biotechnol; 2000 Aug; 18(8):820. PubMed ID: 10932143
    [No Abstract]   [Full Text] [Related]  

  • 28. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 29. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 30. Global biotech expansion taking cues from Bayh-Dole.
    Howard K
    Nat Biotechnol; 2004 Jul; 22(7):919-20. PubMed ID: 15259190
    [No Abstract]   [Full Text] [Related]  

  • 31. A guide to drug discovery. Protecting your inventions: the patent system.
    Webber PM
    Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotech in post-TRIPS India.
    Ramani SV; Pradhan P; Ravi M
    Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
    [No Abstract]   [Full Text] [Related]  

  • 34. Bilski blundering biotech.
    Simmons WJ
    Nat Biotechnol; 2009 Mar; 27(3):245-8. PubMed ID: 19270670
    [No Abstract]   [Full Text] [Related]  

  • 35. Supreme Court boosts licensees in biotech patent battles.
    Waltz E
    Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
    [No Abstract]   [Full Text] [Related]  

  • 36. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
    Garber K
    Science; 2006 May; 312(5775):827. PubMed ID: 16690824
    [No Abstract]   [Full Text] [Related]  

  • 37. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 38. Ten years of biotech gaffes.
    Hodgson J
    Nat Biotechnol; 2006 Mar; 24(3):270-3. PubMed ID: 16525384
    [No Abstract]   [Full Text] [Related]  

  • 39. How many lawyers does it take...greed and legal wrangling could stifle the medical revolution.
    New Sci; 2002 May; 174(2343):3. PubMed ID: 12731531
    [No Abstract]   [Full Text] [Related]  

  • 40. Research tool patents: tips for facing a "pay up now or litigate" ultimatum.
    Gogoris A; Ancona P
    Nat Biotechnol; 2001 Nov; 19(11):1075-7. PubMed ID: 11689855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.